esports varsity jacket
President-elect Trump wants to again rename North America’s tallest peak'NYPD Ignored Her': Video Of Alleged Cop 'Walking Past' Burning Woman On NYC Sub...
Packers getting healthier as season winds down11 distilleries cooked books, caused Rs 13,000 crore tax shortfall: CAGWoman seriously injured in October house fire dies in hospital, Ottawa police say
ANDOVER, Mass. , Dec. 23, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming 43 rd Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 13, 2025 , at 2:15 p.m. Pacific Standard Time / 5:15 p.m. Eastern Standard Time . Event: 43 rd Annual J.P. Morgan Healthcare Conference Date: Monday, January 13, 2025 Time: 2:15 p.m. PST A live and archived webcast of the presentation will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/ . The Company's standard investor presentation is also available through this link. About TransMedics Group, Inc. TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts , the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure. Investor Contact: Brian Johnston Laine Morgan 332-895-3222 Investors@transmedics.com View original content to download multimedia: https://www.prnewswire.com/news-releases/transmedics-to-participate-in-the-43rd-annual-jp-morgan-healthcare-conference-302338418.html SOURCE TransMedics Group, Inc.ANKARA, Turkey (AP) — The recent rapid advance by opposition fighters in Syria shows that Syrian President Bashar Assad must reconcile with his own people and hold dialogue with the opposition, the Turkish foreign minister said Monday. At a joint news conference in Ankara with his Iranian counterpart, Hakan Fidan said Turkey and Iran, which support opposing sides in Syria’s civil war, have agreed to resume diplomatic efforts along with Russia to restore calm days after insurgents launched a lightning offensive and captured almost all of the country’s largest city, Aleppo. The swift advance by fighters that Turkey supports was a huge embarrassment for Assad and it comes at a time when his allies — Iran and groups it backs and Russia — are preoccupied with their own conflicts. The push is among the rebels’ strongest in years and raises the prospect of another violent front reopening in the Middle East when U.S.-backed Israel is fighting Hamas in Gaza and Hezbollah in Lebanon, both Iranian-allied groups. Fidan, whose country has backed forces opposed to Assad, blamed the recent flare-up of the conflict on the Syrian government’s refusal to enter a dialogue with the opposition that Turkey supports. “Recent developments show once again that Damascus must reconcile with its own people and the legitimate opposition,” the Turkish minister said. “Turkey is ready to make all the necessary contribution toward this.” Fidan’s comments emerged amid Turkish frustration that recent efforts toward a reconciliation with Assad have fallen flat. The comments indicated that the shock offensive launched by opposition fighters could be aimed at pressuring the Syrian leader to engage in political talks. Turkey has been seeking to normalize ties with Syria to address security threats from groups affiliated with Kurdish militants along its southern border and to help ensure the safe return of more than 3 million Syrian refugees. Assad has insisted that Turkey’s withdrawal of its forces from northern Syria be a condition for any normalization between the two countries. Iranian Foreign Minister Abbas Araghchi, who visited Assad on Sunday before traveling to Ankara, reiterated Tehran’s full support for the Syrian government. Iran has been one of Assad’s principal political and military supporters and has deployed military advisers and forces after 2011 protests against Assad’s rule turned into an all-out war. Iranian-backed Iraqi militias have deployed in Syria to back the government’s counteroffensive against the insurgents, an Iraqi militia official and a war monitor said Monday. According to the Syrian Observatory for Human Rights, a Britain-based opposition war monitor, some 200 Iraqi militiamen riding on pickups crossed into Syria overnight through the strategic Bou Kamal crossing. They were expected to deploy in Aleppo to support the Syrian army’s pushback against the insurgents, the monitor said. Meanwhile, Associated Press video showed armed insurgents at Aleppo's international airport, one of them standing on a Syrian government flag and others tearing down a poster of Assad. Insurgents were also seen mounting abandoned aircraft and walking around airport grounds strewn with weapons and ammunition boxes. The rebel offensive in Syria has caused concern among neighboring countries that the conflict could spill over. In Iraq, Interior Ministry spokesperson Brig. Gen. Miqdad Miri said security forces have deployed in greater numbers to protect their large border with Syria. Fidan reiterated Turkey’s support for Syria’s territorial integrity, but suggested that Turkey would not hesitate to intervene against Syrian Kurdish militia groups that Turkey considers to be terrorists if they “exploit the environment of instability.” “It was a mistake to ignore the legitimate demands of the opposition and for the (Syrian) regime not to sincerely engage in the political process,” Fidan said. Turkey, he added, "will never, ever allow terrorist organizations that seek to exploit the environment of instability," Fidan said. “We will eliminate any threat to our national security and our people wherever it emerges.” Turkish President Recep Tayyip Erdogan expressed hope that the instability in Syria would come to an end “in line with the legitimate demands of the Syrian people.” He spoke Monday at a joint news conference with the president of Montenegro. Both Fidan and Araghchi said Turkey, Iran and Russia would convene a new three-way meeting to address the conflict in Syria. "We have decided to hold closer consultations and dialogue, and with God’s permission, we will cooperate to further improve the situation toward peace and stability in our region,” Araghchi said. Russia, whose intervention in Syria’s civil war on behalf of Assad was crucial in turning the conflict in his favor, has said it will continue to support him. “We continue our contacts at the appropriate level,” Kremlin spokesman Dmitry Peskov told reporters Monday. “A position will be formed regarding what is needed to stabilize the situation.” The U.S. ambassador to the United Nations, Linda Thomas-Greenfield, said the Assad regime has ignored Security Council resolutions and refused to come to the table. “We are watching that situation very closely, and we will continue to engage with partners in the region to find a path for the situation to go back to calm,” she said. As Syrian and Russian jets continued pounding targets, two airstrikes hit a group of four hospitals and the health directorate building in Idlib city, the Syrian Civil Defense force that operates in opposition-held areas, known as the White Helmets, said. Two people in Idlib University Hospital died after their oxygen machines turned off following the strikes. Ceiling panels and doors at the hospital were blown off, while ambulances and vehicles outside were severely damaged according to footage taken by journalist with The Associated Press at the hospital. At least 15 civilians were killed in Idlib city and province, according to the White Helmets. Syrian Kurds were fleeing the fighting in large numbers after Turkish-backed rebels seized Tel Rifaat from rival U.S.-backed Kurdish authorities. The Kurdish-led Syrian Democratic Forces largely withdrew and called for a humanitarian corridor to allow people to leave safely in convoys toward Aleppo and later to Kurdish-led northeast regions. Chehayeb reported from Beirut. Associated Press writers Nasser Karimi in Tehran, Iran, and Qassim Abdul-Zahra in Baghdad contributed to this report.
Swiss National Bank trimmed its holdings in shares of Globus Medical, Inc. ( NYSE:GMED – Free Report ) by 1.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 219,977 shares of the medical device company’s stock after selling 2,300 shares during the period. Swiss National Bank owned about 0.16% of Globus Medical worth $15,737,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Several other hedge funds and other institutional investors also recently added to or reduced their stakes in GMED. Select Equity Group L.P. bought a new position in Globus Medical during the 2nd quarter worth about $91,711,000. Millennium Management LLC grew its holdings in Globus Medical by 1,171.5% during the 2nd quarter. Millennium Management LLC now owns 1,363,834 shares of the medical device company’s stock worth $93,409,000 after acquiring an additional 1,256,570 shares in the last quarter. Artemis Investment Management LLP bought a new position in Globus Medical during the 3rd quarter worth about $30,656,000. Victory Capital Management Inc. lifted its position in shares of Globus Medical by 855.3% during the second quarter. Victory Capital Management Inc. now owns 381,253 shares of the medical device company’s stock valued at $26,112,000 after buying an additional 341,342 shares during the last quarter. Finally, Swedbank AB purchased a new stake in shares of Globus Medical during the first quarter valued at about $17,433,000. 95.16% of the stock is currently owned by institutional investors. Analyst Ratings Changes Several analysts have commented on GMED shares. Piper Sandler increased their price target on shares of Globus Medical from $80.00 to $100.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. Barclays increased their price target on shares of Globus Medical from $85.00 to $93.00 and gave the company an “overweight” rating in a research report on Thursday, August 8th. Morgan Stanley increased their price target on shares of Globus Medical from $74.00 to $83.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th. Royal Bank of Canada increased their price target on shares of Globus Medical from $80.00 to $92.00 and gave the company an “outperform” rating in a research report on Wednesday, November 6th. Finally, BTIG Research increased their price objective on shares of Globus Medical from $77.00 to $78.00 and gave the company a “buy” rating in a research report on Monday, October 14th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $88.18. Insider Buying and Selling In other news, Director Ann D. Rhoads sold 15,000 shares of the firm’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $70.36, for a total transaction of $1,055,400.00. Following the sale, the director now owns 42,884 shares of the company’s stock, valued at $3,017,318.24. This trade represents a 25.91 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link . Also, CEO Daniel T. Scavilla sold 60,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $80.02, for a total transaction of $4,801,200.00. The disclosure for this sale can be found here . In the last quarter, insiders have sold 110,000 shares of company stock worth $8,512,850. 18.54% of the stock is owned by company insiders. Globus Medical Trading Down 0.2 % Shares of NYSE:GMED opened at $84.72 on Friday. Globus Medical, Inc. has a twelve month low of $44.02 and a twelve month high of $85.30. The company’s 50 day moving average is $74.76 and its 200 day moving average is $70.69. The company has a market cap of $11.54 billion, a PE ratio of 126.45, a price-to-earnings-growth ratio of 1.99 and a beta of 1.17. Globus Medical ( NYSE:GMED – Get Free Report ) last issued its quarterly earnings results on Tuesday, November 5th. The medical device company reported $0.83 earnings per share for the quarter, topping the consensus estimate of $0.65 by $0.18. Globus Medical had a net margin of 3.69% and a return on equity of 9.98%. The company had revenue of $625.71 million for the quarter, compared to the consensus estimate of $604.69 million. During the same quarter in the prior year, the company earned $0.57 EPS. Globus Medical’s quarterly revenue was up 63.1% on a year-over-year basis. Equities research analysts predict that Globus Medical, Inc. will post 2.98 earnings per share for the current fiscal year. Globus Medical Company Profile ( Free Report ) Globus Medical, Inc, a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. Read More Receive News & Ratings for Globus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globus Medical and related companies with MarketBeat.com's FREE daily email newsletter .
I like Martha Stewart. Always have. Two recent documentaries, "Martha" on Netflix and the CNN series "The Many Lives of Martha Stewart," follow the Greek drama that make Stewart a cultural fascination to this day. They recount the jihad against this visionary who came under attack for being a woman with fierce ambition. Admittedly, Stewart's hardedged perfectionism and nuclear-powered drive had created some tension with her product, the "soft" home arts of cooking, flower arranging and chair reupholstering. But did she have to be destroyed? Sure, Stewart engaged in some insider trading that may have seemed nothing more than an innocent stock tip. She shouldn't have lied about it to the FBI. But did journalist Dominick Dunne have to call her the "Goddess of Greed" over a transaction that saved the creator of a billion-dollar business only $45,673? It sure didn't merit five months in prison. In 1987, the cultural hyenas jumped on her for signing a $5 million contract with Kmart. Stewart was allegedly "selling out" the domestic lifestyle she had cultivated, moving away from authenticity toward mass production and profit. Heaven forfend. The year before, The Disney Co.'s CEO walked off with a $90 million severance check after 14 months of undistinguished performance. She was tenacious. So what? Male executives wore that badge proudly. This woman built a business empire based on creating artistic cheese trays and making wreaths from dry leaves. Try that, Elon Musk. Some of her trouble came in the sub-message that our home lives had turned slovenly because Americans had stopped caring about family dinners and dust balls under the sofa. Some translated that not as a call to do better but as an indictment. But Stewart had no army. Those who accused her of creating unrealistic expectations for women juggling work and family should have been asked: Whose expectations? One could simply enjoy watching her on TV or reading her magazine, Martha Stewart Living. Her projects were properly labeled "aspirational." I once tried to follow her instructions for coloring cloth with natural vegetable dyes. Two hours later, I ended up with blotchy fabric and hands stained by beet juice. I tried, I failed, and I had a funny story to tell. I was intrigued by her demonstration on how to roll an ironed tablecloth in parchment paper to prevent wrinkles. And how nice that she could whip up 80 perfectly iced little cakes in no time. I can't do a single backflip. Must I resent Simone Biles for executing a triple-double in one move? It took Superwoman strength to plant an orchard with 122 trees and who knows how many rose bushes. One interviewer noted that people living in Detroit or New York City couldn't do rose gardens. She responded, "But yes, they want roses." The fantasy was more than half the point. Women were among her leading inquisitors. One called her "the most intimidating homemaker on earth." Another female interviewer tells her, "Either they worship you or they say you make us crazy." There was a third possibility — that they found her entertaining. Stewart can lay claim to two heroic feats: She played a big part in improving the quality of American homelife. And she rebuilt a business that had been left for dead. Above all, Martha was a great tough broad. You saw how TV's Larry King kept badgering her about her failed marriage in a way that would have seemed bizarre had the executive been a man. "I had sacrificed a marriage because of the allure of a great job," she finally relented. And she didn't regret it? She did not. I like Stewart, still going strong at 83. More than ever. Harrop, who lives in New York City and Providence, Rhode Island, writes for Creators Syndicate: fharrop@gmail.com . Get local news delivered to your inbox!
Tulane QB Mensah transfers to Duke
Trump taps immigration hard-liner Kari Lake as head of Voice of America